Gazyva (obinutuzumab)

pCPA File Number: 21015

Negotiation Status:

Concluded with an LOI

Indication(s):

Follicular Lymphoma

Sponsor/Manufacturer:

Hoffmann-La Roche Ltd.

CDA-AMC Project Number:

PC0091-000

pCPA Engagement Letter Issued:

2017-10-10

Negotiation Process Concluded:

2018-01-16